Clinical Trial Update: EXPAREL IPSA Block in Knee Arthroplasty [Phase 4]

View source ↗

Summary

Clinical trial update indicates EXPAREL is being studied for an IPSA block in knee arthroplasty in a Phase 4 study, with enrollment by invitation ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Campbell Clinic | Conditions: Pain, Postoperative, Osteo Arthritis Knee | Phase 4 | Status: ENROLLING_BY_INVITATION